A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies

David Geffen School of Medicine at UCLA, Los Angeles, California, United States

Stanford University, Stanford, California, United States

Georgetown University, Washington D.C., District of Columbia, United States

Florida Cancer Specialist, Fort Myers, Florida, United States

University of Miami - Sylvester Comprehensive Cancer Center, Miami, Florida, United States

Florida Cancer Specialists & Research Institute, West Palm Beach, Florida, United States

RUSH University Medical Center, Chicago, Illinois, United States

Northwestern University, Evanston, Illinois, United States

University of Kentucky, Lexington, Kentucky, United States

Massachusetts General Hospital, Boston, Massachusetts, United States

Karmanos, Detroit, Michigan, United States

Memorial Sloan Kettering Cancer Center, New York, New York, United States

NYU Langone Health, New York, New York, United States

The Ohio State University - Comprehensive Cancer Center, Columbus, Ohio, United States

Providence Portland Medical Centre, Portland, Oregon, United States

Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Sarah Cannon Research Institute, Nashville, Tennessee, United States

MD Anderson Cancer Center, Houston, Texas, United States

Virginia Cancer Specialists, Fairfax, Virginia, United States

Washington University - School of Medicine, Seattle, Washington, United States

University of Washington - Fred Hutchinson Cancer Center, Seattle, Washington, United States

Institut Bergonié, Bordeaux, France

Centre François Baclesse, Caen, France

Centre Léon Bérard, Lyon, France

Assistance Publique - Hôpitaux de Marseille, Marseille, France

Institut Gustave Roussy, Paris, France

Charité Comprehensive Cancer Center, Berlin, Germany

Universitätsklinikum Köln, Cologne, Germany

Ludwig-Maximilians-Universität München (LMU), München, Germany

Centro di Riferimento Oncologico IRCCS, Aviano, Italy

IRCCSS AOU Bologna, Bologna, Italy

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy

Istituto Nazionale Tumori Regina Elena, Roma, Italy

Azienda Ospedaliero-Universitaria San Luigi Gonzaga, Torino, Italy

Uniwersyteckie Centrum Kliniczne, Gdansk, Poland

Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie, Warsaw, Poland

Hospital Universitario de A Coruña, A Coruña, Spain

Hospital Universitario Vall d'Hebron, Barcelona, Spain

Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain

Hospital Universitario Ramon y Cajal, Madrid, Spain

Hospital Universitario 12 de Octubre, Madrid, Spain

Hospital Madrid Sanchinarro, Madrid, Spain

Hospital Virgen de la Victoria de Malaga, Málaga, Spain

Tawam Hospital, Al Ain City, Abu Dhabi Emirate, United Arab Emirates

Sheik Shakhbout Medical City (SSMC), Abu Dhabi, United Arab Emirates

Cleveland Clinic Abu Dhabi (CCAD), Abu Dhabi, United Arab Emirates

University College London Hospital (UCLH), London, United Kingdom

Guy's and St Thomas' Hospital NHSFT, London, United Kingdom

The Royal Marsden NHSFT, London, United Kingdom

The Christie Hospital NHSFT, Manchester, United Kingdom

Sheffield Teaching Hospitals NHSFT, Sheffield, United Kingdom